Your browser doesn't support javascript.
loading
Nandrolone-Induced Tumor Progression in Hormone-Sensitive Prostate Cancer.
Goyal, Shikha; Madan, Renu; Kumar, Narendra; Kumar, Rajender.
Afiliación
  • Goyal S; From the Departments of Radiotherapy and Oncology.
  • Madan R; From the Departments of Radiotherapy and Oncology.
  • Kumar N; From the Departments of Radiotherapy and Oncology.
  • Kumar R; Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Clin Nucl Med ; 47(4): e372-e374, 2022 Apr 01.
Article en En | MEDLINE | ID: mdl-35044958
ABSTRACT: Hormone-sensitive prostate cancer responds favorably to testosterone suppression induced by GnRH analogs or antagonists. This effect may theoretically be countered by anabolic steroids. We describe a patient of a recurrent hormone-sensitive prostate cancer who was on salvage androgen deprivation therapy with degarelix and developed rapid progression after over-the-counter nandrolone injections.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Nandrolona Tipo de estudio: Diagnostic_studies Límite: Humans / Male Idioma: En Revista: Clin Nucl Med Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Nandrolona Tipo de estudio: Diagnostic_studies Límite: Humans / Male Idioma: En Revista: Clin Nucl Med Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos